Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…

COVID-19, caused by SARS-CoV-2, is a virulent pneumonia, with >4,000,000 confirmed
cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and …

SARS-CoV-2 caused a major outbreak of severe pneumonia (COVID-19) in humans. Viral
RNA was detected in multiple organs in COVID-19 patients. However, infectious SARS-CoV-2 …

Virus-specific T cells play essential roles in protection against multiple virus infections, including
SARS-CoV and MERS-CoV. While SARS-CoV-2–specific T cells have been identified in …

Disease progression prediction and therapeutic drug target discovery for Coronavirus disease
2019 (COVID-19) are particularly important, as there is still no effective strategy for severe …

The pathogenesis of COVID-19 is still elusive, which impedes disease progression prediction,
differential diagnosis, and targeted therapy. Plasma cell-free RNAs (cfRNAs) carry unique …

Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted
most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Human coronavirus 229E (HCoV-229E) and NL63 (HCoV-NL63) are endemic causes of
upper respiratory infections such as the “common cold” but may occasionally cause severe …

Coronavirus 2019 (COVID-19) is a complex disease that affects billions of people worldwide.
Currently, effective etiological treatment of COVID-19 is still lacking; COVID-19 also causes …

Characterizing the serologic features of asymptomatic SARS-CoV-2 infection is imperative
to improve diagnostics and control of SARS-CoV-2 transmission. In this study, we evaluated …